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Caesarean section surgical techniques: 3 year follow-up of 
the CORONIS fractional, factorial, unmasked, randomised 
controlled trial
The CORONIS collaborative group*
Summary
Background The CORONIS trial reported diﬀ erences in short-term maternal morbidity when comparing ﬁ ve pairs of 
alternative surgical techniques for caesarean section. Here we report outcomes at 3 years follow-up.
Methods The CORONIS trial was a pragmatic international 2 × 2 × 2 × 2× 2 non-regular fractional, factorial, unmasked, 
randomised controlled trial done at 19 sites in Argentina, Chile, Ghana, India, Kenya, Pakistan, and Sudan. Pregnant 
women were eligible if they were to undergo their ﬁ rst or second caesarean section through a planned transverse 
abdominal incision. Women were randomly assigned by a secure web-based allocation system to one intervention from 
each of the three assigned pairs. All investigators, surgeons, and participants were unmasked to treatment allocation. In 
this follow-up study, we compared outcomes at 3 years following blunt versus sharp abdominal entry, exteriorisation of 
the uterus for repair versus intra-abdominal repair, single versus double layer closure of the uterus, closure versus non-
closure of the peritoneum, and chromic catgut versus polyglactin-910 for uterine repair. Outcomes included pelvic pain; 
deep dyspareunia; hysterectomy and outcomes of subsequent pregnancies. Outcomes were assessed masked to the 
original trial allocation. This trial is registered with the Current Controlled Trials registry, number ISRCTN31089967. 
Findings Between Sept 1, 2011, and Sept 30, 2014, 13 153 (84%) women were followed-up for a mean duration of 
3·8 years (SD 0·86). For blunt versus sharp abdominal entry there was no evidence of a diﬀ erence in risk of abdominal 
hernias (adjusted RR 0·66; 95% CI 0·39–1·11). We also recorded no evidence of a diﬀ erence in risk of death or 
serious morbidity of the children born at the time of trial entry (0·99, 0·83–1·17). For exteriorisation of the uterus 
versus intra-abdominal repair there was no evidence of a diﬀ erence in risk of infertility (0·91, 0·71–1·18) or of ectopic 
pregnancy (0·50, 0·15–1·66). For single versus double layer closure of the uterus there was no evidence of a diﬀ erence 
in maternal death (0·78, 0·46–1·32) or a composite of pregnancy complications (1·20, 0·75–1·90). For closure versus 
non-closure of the peritoneum there was no evidence of a diﬀ erence in any outcomes relating to symptoms associated 
with pelvic adhesions such as infertility (0·80, 0·61–1·06). For chromic catgut versus polyglactin-910 sutures there 
was no evidence of a diﬀ erence in the main comparisons for adverse pregnancy outcomes in a subsequent pregnancy, 
such as uterine rupture (3·05, 0·32–29·29). Overall, severe adverse outcomes were uncommon in these settings.
Interpretation Although our study was not powered to detect modest diﬀ erences in rare but serious events, there was 
no evidence to favour one technique over another. Other considerations will probably aﬀ ect clinical practice, such as 
the time and cost saving of diﬀ erent approaches.
Funding UK Medical Research Council and the Department for International Development.
Copyright © Brocklehurst et al. Open Access article distributed under the terms of CC BY.
Introduction
Caesarean section is one of the most commonly 
undertaken operations worldwide and is not done in a 
standardised way. In the CORONIS trial, we previously 
reported the short-term outcomes associated with 
diﬀ erent surgical techniques at caesarean section in 
15 935 women in low-income and middle-income 
settings .1 We compared blunt versus sharp abdominal 
entry, exteriorisation of the uterus for repair versus intra-
abdominal repair, single versus double layer closure of 
the uterus, closure versus non-closure of the peritoneum 
(pelvic and parietal), and chromic catgut versus 
polyglactin-910 for uterine repair. Our ﬁ ndings showed 
no clear beneﬁ ts of any of the randomised comparisons 
on a range of short-term outcomes (up to 6 weeks after 
the surgery). Many of the important maternal outcomes 
associated with diﬀ erent surgical techniques will be 
apparent in the longer term, including the functional 
integrity of the uterine and abdominal scar during 
subsequent pregnancies and other long-term 
postoperative eﬀ ects such as chronic pelvic pain, 
infertility, and symptoms related to peritoneal and bowel 
adhesions, including bowel obstruction.
In this CORONIS follow-up study, we aimed to measure 
and compare the incidence of outcomes between the 
groups of women who took part in the CORONIS trial at 
least 3 years after their CORONIS caesarean section. The 
protocol for the follow-up study has been published.2
Lancet 2016; 388: 62–72
Published Online
May 4, 2016
http://dx.doi.org/10.1016/
S0140-6736(16)00204-X
See Comment page 8
*Investigators listed at end 
of report
Correspondence to:
Prof Peter Brocklehurst, Institute 
for Women’s Health, University 
College London, 
London WC1E 6AU, UK
p.brocklehurst@ucl.ac.uk
For the protocol see 
http://bmcpregnancychildbirth.
biomedcentral.com/articles/ 
10.1186/ 1471-2393-13-215 
Articles
www.thelancet.com   Vol 388   July 2, 2016 63
Methods
Study design and participants
The methods of the trial have already been described, but 
in summary, women were eligible for this 2 × 2 × 2 × 2 × 2 
non-regular fractional factorial randomised trial if they 
were undergoing delivery by lower segment caesarean 
section through a transverse abdominal incision, and 
had no more than one previous caesarean section, and 
there was no clear indication for a particular surgical 
technique or material to be used.2 Women were not 
eligible for the follow-up study if they had been randomly 
assigned in error, withdrawn consent from the trial, 
delivered vaginally at the time of recruitment to 
CORONIS, opted out of the follow-up study, no data were 
collected after trial entry.
The study was approved by Oxford Tropical Research 
Ethics Committee (OXTREC; 013-06a) and by the relevant 
research ethics committees in each of the participating 
countries and sites. The CORONIS follow-up study 
steering committee provided independent oversight.
Data collection
Telephone contact was maintained regularly with all 
women eligible for follow-up throughout the follow-up 
period to facilitate a face-to-face assessment at least 3 years 
after their CORONIS caesarean section. During the 
Research in context 
Evidence before this study
Before this follow-up study, several reviews, including Cochrane 
systematic reviews, had synthesised available evidence of the 
diﬀ erent surgical techniques included in the CORONIS trial. 
Based on this evidence, clinical practice guidelines had been 
made with recommendations about the diﬀ erent approaches. 
However, most evidence for this guidance came from studies 
that rarely measured outcomes beyond the immediate 
postoperative period. With regards to blunt versus sharp 
abdominal entry, for exteriorisation versus intra-abdominal 
repair of the uterus, no studies compared long-term outcomes 
for this intervention pair. For single versus double layer closure 
of the uterine incision, uterine scar integrity after single versus 
double layer uterine closure had been assessed in the longer 
term. A systematic review of observational studies failed to ﬁ nd 
evidence of a clear association between single layer closure and 
uterine rupture. For closure versus non-closure of the 
peritoneum and for subsequent intra-abdominal adhesions, 
studies only followed up women who had a subsequent 
laparotomy (including a repeat caesarean section) or 
laparoscopy. Two systematic reviews looked at the longer term 
eﬀ ect of closure versus non-closure of the peritoneum on 
adhesion formation. Both reviews agreed that the available 
evidence is limited because most ﬁ ndings came from small 
observational studies that had a high risk of bias; the 
investigators suggested in their conclusions that non-closure of 
the peritoneum was associated with an increased risk of 
intra-abdominal adhesions, of all grades. For chromic catgut 
versus polyglactin-910 for uterine repair, no studies compared 
long term outcomes for this intervention pair.
Added value of this study
Our results provide the ﬁ rst evidence of the long-term eﬀ ects of 
exteriorisation versus intra-abdominal repair of the uterus, and 
for chromic catgut versus polyglactin-910 for repair of the 
uterus. For sharp versus blunt abdominal entry, the risk of 
incisional hernias after caesarean section has been studied in 
the Danish population. There were 134 hernias recorded in 
57 564 women (a 10 year incidence of 0·2%). The study was not 
able to establish whether the abdominal entry approach used at 
the time of the caesarean section was blunt or sharp. Therefore, 
CORONIS provides evidence that the risk of later hernia 
formation is very small, and we noted no diﬀ erence in the risk 
between the two approaches. For closure versus non-closure of 
the peritoneum, the outcome measures in previous studies vary, 
but rely on ﬁ nding evidence of pelvic adhesions. The relevant 
Cochrane review includes follow-up studies from four 
randomised trials that ﬁ nd no evidence of an increased risk of 
adhesions, although the studies included are small. Because 
intra-abdominal adhesions are often asymptomatic, it is diﬃ  cult 
to interpret much of this evidence. In the CORONIS study we 
noted no diﬀ erence in symptoms reported by more than 
8000 women assessed in this intervention pair, suggesting that 
even if there are diﬀ erences in the incidence of adhesion 
formation, these are unlikely to produce symptomatic disease 
for most women. 
Implications of all the available evidence
Polyglactin-910 costs at least twice as much as chromic catgut 
and the ﬁ nding of no beneﬁ t with the use of polyglactin-910 
suggests that chromic catgut should be the suture material of 
choice for uterine repair in appropriate settings. The absence of 
evidence of any diﬀ erence between closure versus non-closure 
of the peritoneum also suggests that non-closure is to be 
preferred, not simply because it may save time as previous 
recommendations suggest, but because it will result in the use 
of fewer sutures, therefore decreasing costs. The use of routine 
exteriorisation to repair the uterus can also be discouraged as it 
confers no beneﬁ t. If double layer closure of the uterus 
frequently employs two sutures, then single layer closure would 
also decrease costs. For those surgeons who routinely repair the 
uterus in two layers with a single suture, the only potential 
impact on the operation is the time taken, although there were 
no apparent diﬀ erences in the duration of the operation 
between single and double layer closure in CORONIS.
Other implications include that the techniques used at 
caesarean section do not need to be modiﬁ ed by whether the 
caesarean section is done before or after the onset of labour, or 
by whether the caesarean section being performed is the ﬁ rst or 
second caesarean section. 
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assessment, a detailed medical history was taken from the 
woman by a speciﬁ cally trained health professional. 
Details of the woman’s general and reproductive health 
and history of all subsequent pregnancies were recorded 
on the health assessment questionnaire.3 Any hospital 
admissions for a speciﬁ ed range of disorders (eg, 
subsequent pregnancy complications, including uterine 
rupture or dehiscence, hysterectomy, placenta praevia, or 
other morbidity including non-pregnancy related 
hysterectomy, and laparoscopy or laparotomy) were 
followed up by a review of the hospital notes and 
completion of the relevant event report form, wherever 
possible.4 Not all women could be seen in person, and 
telephone follow-up interviews were undertaken when a 
face-to-face assessment was not possible.
Outcomes
The outcomes measured for the follow-up study were: 
following the CORONIS birth and before any subsequent 
pregnancy: any new onset or worsening of pelvic pain; 
dysmenorrhoea;  deep dyspareunia; urinary symptoms; 
diagnostic laparoscopy or diagnostic laparotomy (not 
related to pregnancy); hysterectomy or tubal or ovarian 
surgery (not related to pregnancy); bladder or bowel 
damage in those women who had surgery, excluding 
diagnostic laparoscopy and diagnostic laparotomy (not 
related to pregnancy); after the CORONIS birth and before 
any subsequent pregnancy, any new onset of abdominal 
hernia; bowel obstruction; woman’s death; number of 
women with no subsequent pregnancy; voluntary 
infertility; involuntary infertility; use of fertility treatments; 
number of women having any subsequent pregnancy and 
for these women, the following outcomes were measured: 
inter-pregnancy interval from the CORONIS birth to the 
end of the subsequent pregnancy (regardless of loss or 
birth); miscarriage of the pregnancy subsequent to the 
CORONIS birth; ectopic pregnancy; for the birth following 
the CORONIS birth: gestation at delivery (by best 
15 935 patients randomly assigned 
Women eligible for 
assessment (% of women 
randomly assigned)
Women not eligible for 
assessment
Reasons:
 Excluded*
 Opted out of follow-up
9381 allocated to
 abdominal entry
9941 allocated to
 repair of uterus
9416 allocated to
 closure of uterus
9798 allocated to closure
 of peritoneum
9269 allocated to uterine 
 repair sutures
4598 (98%)
 80
 17
4608 (99%)
 59
 19
4867 (99%)
 75
 32
4862 (99%)
 73
 32
4613 (99%)
 69
 23
4621 (99%)
 66
 24
4783 (99%)
 67
 41
4816 (99%)
 57
 34
4567 (99%)
 43
 25
4564 (99%)
 47
 23
Women randomly assigned 4695 4686
Blunt
entry
Sharp
entry
4974 4967
Exterior
repair
Intra-abdominal
repair
4705 4711
Single
closure
Double
closure
4891 4907
Closure Non-closure
4635 4634
15 633 (99%)
 212
 90
Women assessed 
(% of women eligible to be
assessed)
Women not assessed
Reasons:
 Lost in follow-up
 Known deaths
3878 (84%)
    737 (16%)
 691
 29
3873 (84%)
   754 (16%)
 702
 33
4092 (84%)
   807 (16%)
 749
 26
4136 (85%)
   758 (15%)
 703
 23
3709 (80%)
   927 (20%)
 879
 25
3702 (80%)
   943 (20%)
 887
 32
4036 (84%)
   788 (16%)
 723
 24
4087 (84%)
   763 (16%)
 704
 24
3974 (87%)
   618 (13%)
 571
 22
3972 (87%)
   615 (13%)
 564
 28
13 153 (84%)
   2570 (16%)
 2391
 89
Women with a subsequent
pregnancy 
(% of women assessed)
1612 (42%) 1637 (42%) 1653 (40%) 1656 (40%) 1889 (51%) 1904 (51%) 1688 (42%) 1705 (42%) 1861 (47%) 1842 (46%) 5815 (44%)
Women with a subsequent
viable pregnancy 
(% of women assessed)
1367 (35%) 1396 (36%) 1407 (34%) 1413 (34%) 1611 (43%) 1624 (44%) 1411 (35%) 1438 (35%) 1661 (42%) 1648 (42%) 4992 (38%)
15 935
Chromic
catgut
Polyglactin-
910
Total
Time to follow-up (years) 
 Mean [SD]
 (range)
4·0 [0·89]
(2·6 to 6·9)
4·0 [0·89]
(2·6 to 6·9)
3·7 [0·88]
(2·3 to 6·9)
3·7 [0·85]
(2·5 to 6·9)
3·8 [0·89]
(2·3 to 6·9)
3·8 [0·88]
(2·3 to 6·8)
3·7 [0·80]
(2·6 to 6·6)
3·7 [0·81]
(2·6 to 6·6)
3·9 [0·84]
(2·3 to 6·9)
3·9 [0·85]
(2·3 to 6·9)
3·8 [0·86]
(2·3 to 6·9)
Figure 1: Participant ﬂ ow diagram
*Reasons for exclusion: women randomly assigned in error, women who withdrew consent from main trial, baseline data not received, vaginal deliveries at the time of recruitment to CORONIS. Six 
additional cases of women randomly assigned in error have been found since publication of the main results.
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estimate) of the ﬁ rst viable pregnancy (viable pregnancy 
deﬁ ned as gestational age > 24 or >28 weeks depending on 
country speciﬁ c deﬁ nition); stillbirth; neonatal death; 
mode of delivery as non-instrumental vaginal; 
instrumental vaginal; pre-labour caesarean section; in 
labour caesarean section; other pregnancy complications 
including: uterine rupture, uterine scar dehiscence, 
placenta praevia, morbidly adherent placenta, abruption, 
postpartum haemorrhage requiring transfusion, severe 
infection within 6 weeks post partum, hysterectomy up to 
6 weeks post partum, manual removal of placenta; bladder 
or bowel damage at the time of subsequent caesarean 
section; death or serious morbidity of the child who was 
born at the time of CORONIS participation (for the sharp 
vs blunt abdominal entry intervention pair). 
Many outcomes are potentially relevant for each 
intervention pair; however, some outcomes are more 
likely to be aﬀ ected by some interventions than others. 
For example, interventions such as closure or 
non-closure of the peritoneum can have an eﬀ ect on 
subsequent pelvic adhesion formation, so outcomes 
such as infertility and pelvic pain were regarded as most 
important for this intervention pair. For single versus 
double layer closure of the uterus, the main outcomes of 
interest relate to subsequent pregnancy, whereas 
outcomes such as dyspareunia and infertility were 
deemed of secondary interest. Therefore, we categorised 
comparisons into main comparisons of interest and 
secondary comparisons of interest. This approach was 
pre-speciﬁ ed considering biological plausibility and to 
account for the dangers of multiple testing. The main 
comparisons of interest are reported here and the 
remaining comparisons, along with a description of the 
process for agreeing the main and secondary 
comparisons of interest, are in the appendix.
Statistical analysis
The original trial recruited 15 935 women, with at least 
9000 women in each intervention pair. We assumed an 
overall response rate of at least 80% for the follow-up, 
and an assumption that 80% of these women would 
have a subsequent pregnancy during the follow-up, 
which would result in nearly 6000 women in each 
intervention pair with a subsequent pregnancy. This 
number would be suﬃ  cient to detect modest but 
clinically important diﬀ erences between any principal 
comparisons for this population. The statistical power 
available, based on a ﬁ xed sample size, for a range of 
event rates on a selection of outcomes was high (>90%), 
although there were no published data for estimates for 
many of the outcomes of interest from low-resource and 
middle-resource settings.2,5,6
A detailed statistical analysis plan was developed and 
approved by the study steering committee before the 
ﬁ nal analysis. All outcomes were analysed in the groups 
into which the women were randomly allocated 
irrespective of the technique received.
Baseline demographic and clinical characteristics are 
described separately for the ﬁ ve intervention pairs. 
Outcome variables were derived with information 
collected on the Health Assessment Questionnaire. 
Because clinical details of hospital admissions would not 
be known by most participants during the medical 
history interview, data for the event report form were 
deemed more reliable, when available. All comparative 
analyses were done adjusting for the minimisation 
factors in-labour or not in-labour caesarean section and 
number of previous caesarean sections (none or one) 
where possible. Binary outcomes were analysed with log 
binomial regression models and results presented as 
adjusted risk ratios. Continuous outcomes were analysed 
with linear regression models and results presented as 
adjusted diﬀ erences in means. Time to the ﬁ rst 
subsequent pregnancy after CORONIS used Cox 
regression methods and a hazard ratio is presented. For 
the main comparisons, 95% CIs are given and 99% CIs 
for secondary comparisons.
To facilitate the interpretation of the ﬁ ndings appropriate 
to the outcome analysed, the analysis populations varied 
and were prespeciﬁ ed in the statistical analysis plan. 
Outcomes relating to deaths of women or children in 
CORONIS were based on all women eligible for the 
follow-up study (ie, women eligible for assessment). For 
most of the remaining outcomes, analyses were based on 
Blunt 
abdominal 
entry
Sharp 
abdominal 
entry
Adjusted risk ratio 
(95% CI)
Women’s health
Women assessed 3878 3873 ..
Abdominal hernias* 23/
3878 (<1%)
35/
3873 (<1%)
0·66 (0·39–1·11)
CORONIS children
Liveborn children of women eligible to be assessed 4725 4772 ..
Known deaths or serious morbidity of CORONIS 
children
244/
4725 (5%)
249/
4772 (5%)
0·99 (0·83–1·17)
*After the CORONIS birth, any new onset.
Table 1: Outcomes associated with abdominal entry
Exterior repair Intra-abdominal 
repair
Adjusted risk ratio 
(95% CI)
Reproductive status
Women assessed 4092 4136 ..
Involuntary infertility 109/4092 (3%) 121/4136 (3%) 0·91 (0·71–1·18)
Use of fertility treatments 9/4090 (<1%) 15/4136 (<1%) 0·61 (0·27–1·38)
Subsequent pregnancies
Women with a subsequent pregnancy* 1627 1632 ..
Ectopic pregnancy 4/1627 (<1%) 8/1632 (<1%) 0·50 (0·15–1·66)
*Excludes 26 women with exteriorisation and 24 women with intra-abdominal repair, who were pregnant at time of 
assessment. Missing data are <1% unless otherwise stated.
Table 2: Outcomes associated with repair of uterus
For the Health Assessment 
Questionnaire see https://www.
npeu.ox.ac.uk/coronis-follow-
up/documents
See Online for appendix
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all surviving women for whom follow-up data were 
available (women assessed). Pregnancy related outcomes 
for which viability was not relevant (eg, ectopic pregnancy) 
were based on women with a subsequent pregnancy. To 
take account of the potential for diﬀ erences in the 
pregnancy rate between any two interventions being 
compared, we analysed the outcomes relating to a 
subsequent viable pregnancy, such as uterine rupture, 
with two populations: women who subsequently had at 
least one viable pregnancy as a primary analysis and 
women assessed as a secondary analysis.
The primary analysis of the outcome death or serious 
morbidity of the CORONIS children excluded stillbirths. 
We also did a secondary analysis including stillbirths. 
Outcomes for infants from multiple births were expected 
to be correlated and therefore a clustering eﬀ ect might be 
anticipated. For the primary analysis of all neonatal and 
child outcomes, all babies or CORONIS children were 
treated as independent.7 A sensitivity analysis assessed 
the eﬀ ect of allowing for potential clustering.
Prespeciﬁ ed subgroup analyses were in-labour or not in-
labour caesarean section and number of previous 
caesarean sections (none or one). Stratum-speciﬁ c eﬀ ect 
estimates with 95% CIs are presented on forest plots, by 
pair of interventions, with a test for interaction. Plausible 
treatment interactions were diﬃ  cult to pre-specify. The 
same strategy for the analysis of interactions for the short 
term outcomes was employed for this report of the long 
term outcomes—ie, analyses of interactions would only be 
done for the main comparisons; and three-way interactions 
would not be investigated unless there was strong evidence 
of a two-way interaction in the presence of main eﬀ ects.
Sensitivity analyses on the main comparisons of 
interest were pre-speciﬁ ed relating to the timing of the 
completion of the follow-up assessment: ﬁ rst, analyses 
were restricted to a follow-up window of 3 years (within 
3 months); to address variations in time at risk, we used 
Cox regression methods for outcomes related to delivery 
using date of randomisation and date of delivery to 
indicate the time at risk; to investigate the consistency of 
eﬀ ect over time to follow-up for outcomes not related to 
delivery, time to follow-up was dichotomised with cutoﬀ  
points driven by the data, and subgroup analyses were 
done using tests of interaction.
Generalisability of each of the analysis populations 
compared with those not included was assessed on selected 
Single closure Double closure Adjusted risk ratio 
(95% CI)
Women’s health
Women eligible to be assessed 4613 4621 ..
Known deaths 25/4613 (<1%) 32/4621 (<1%) 0·78 (0·46–1·32)
Subsequent pregnancies
Babies of women with a subsequent viable pregnancy* 1630 1646 ..
Stillbirth† 34/1630 (2%) 28/1646 (2%) 1·23 (0·75–2·01)
Neonatal death†‡ 32/1595 (2%) 34/1616 (2%) 0·96 (0·59–1·54)
Method of delivery†
Non-instrumental vaginal 309/1630 (19%) 288/1646 (18%) ..
Instrumental vaginal 9/1630 (<1%) 5/1646 (<1%) ..
Pre-labour caesarean section 1025/1630 (63%) 1076/1646 (65%) ..
In labour caesarean section 287/1630 (18%) 277/1646 (17%) ..
All caesarean sections 1312/1630 (81%) 1353/1646 (82%) 0·98 (0·95–1·01)
Women with a subsequent viable pregnancy* 1611 1624 ..
Other pregnancy complications, composite†§ 38/1609 (2%) 32/1623 (2%) 1·20 (0·75–1·90)
Uterine rupture† 1/1610 (<1%) 2/1624 (<1%) 0·50 (0·05–5·51)
Uterine scar dehiscence† 4/1609 (<1%) 2/1624 (<1%) 2·01 (0·37–10·95)
Placenta praevia† 5/1609 (<1%) 4/1624 (<1%) 1·23 (0·33–4·57)
Morbidly adherent placenta† 0/1609 2/1624 (<1%) -
Abruption† 6/1610 (<1%) 4/1624 (<1%) 1·51 (0·43–5·35)
Post-partum haemorrhage requiring transfusion of >1 unit of whole blood or 
packed cells†
8/1610 (<1%) 7/1624 (<1%) 1·15 (0·42–3·16)
Severe infection within 6 weeks post partum† 14/1610 (<1%) 15/1623 (<1%) 0·94 (0·46–1·94)
Hysterectomy up to 6 weeks post partum† 1/1610 (<1%) 1/1624 (<1%) 1·00 (0·06–15·90)
Manual removal of placenta† 4/1610 (<1%) 0/1624 ..
Missing data are <1% unless otherwise stated. *Viability could not be assessed if gestational age was not recorded. †For the birth after the CORONIS birth. ‡Excludes 
stillbirths. §Includes: uterine rupture, uterine scar dehiscence, placenta praevia, morbidly adherent placenta, abruption, post-partum haemorrhage requiring transfusion, 
severe infection within 6 weeks, post-partum hysterectomy up to 6 weeks post partum, manual removal of placenta. 
Table 3: Outcomes associated with closure of uterus
Articles
www.thelancet.com   Vol 388   July 2, 2016 67
Catgut Polyglactin-910 Adjusted risk ratio 
(95% CI)
Women’s health
Denominator, women eligible to be assessed 4567 4564
Known deaths 22/4567 (<1%) 28/4564 (1%) 0·79 (0·45–1·37)
Subsequent pregnancies
Denominator, babies of women with a subsequent viable pregnancy* 1686 1670
Stillbirth† 43/1686 (3%) 33/1670 (2%) 1·29 (0·82–2·02)
Neonatal death†‡ 27/1643 (2%) 28/1634 (2%) 0·96 (0·57–1·61)
Mode of delivery†
Non-instrumental vaginal 190/1685 (11%) 199/1670 (12%) ..
Instrumental vaginal 23/1685 (1%) 23/1670 (1%) ..
Pre-labour caesarean section 1237/1685 (73%) 1226/1670 (73%) ..
In-labour caesarean section 235/1685 (14%) 222/1670 (13%) ..
All caesarean sections 1472/1685 (87%) 1448/1670 (87%) 1·01 (0·98–1·03)
Denominator, women with a subsequent viable pregnancy* 1661 1648
Other pregnancy complications, composite†§ 42/1660 (2·5%) 35/1646 (2%) 1·19 (0·76–1·86)
Uterine rupture† 3/1660 (<1%) 1/1647 (<1%) 3·05 (0·32–29·29)
Uterine scar dehiscence† 2/1660 (<1%) 3/ 1646 (<1%) 0·67 (0·11–4·02)
Placenta praevia† 8/1660 (<1%) 8/1646 (<1%) 1·00 (0·37–2·64)
Morbidly adherent placenta† 2/1660 (<1%) 3/1646 (<1%) 0·68 (0·11–4·06)
Abruption† 6/1660 (<1%) 2/1647 (<1%) 2·98 (0·60–14·74)
Post-partum haemorrhage requiring
transfusion of >1 unit of whole blood or
packed cells†
8/1660 (<1%) 7/1647 (<1%) 1·14 (0·41–3·12)
Severe infection within 6 weeks post partum† 16/1660 (1%) 9/1647 (<1%) 1·74 (0·77–3·94)
Hysterectomy up to 6 weeks post partum† 1/1661 (<1%) 2/1647 (<1%) 0·50 (0·05–5·53)
Manual removal of placenta† 5/1661 (<1%) 7/1647 (<1%) 0·71 (0·23–2·24)
Missing data are <1% unless otherwise stated.*Viability could not be assessed if gestational age was not recorded. †For the birth following the CORONIS birth. ‡Excludes 
stillbirths. §Includes: uterine rupture, uterine scar dehiscence, placenta praevia, morbidly adherent placenta, abruption, post-partum haemorrhage requiring transfusion, 
severe infection within 6 weeks post-partum hysterectomy up to 6 weeks post partum, manual removal of placenta. 
Table 5: Outcomes associated with uterine repair sutures
Closure of peritoneum Non-closure of 
peritoneum
Adjusted risk ratio 
(95% CI)
Women’s health
Women assessed 4036 4087 ..
Pelvic pain* 205/4036 (5%) 231/4087 (6%) 0·90 (0·75–1·08)
Deep dyspareunia* 145/4036 (4%) 134/4087 (3%) 1·09 (0·87–1·38)
Diagnostic laparoscopy/laparotomy† 1/4036 (<1%) 4/4087 (<1%) 0·25 (0·03–2·26)
Hysterectomy or tubal/ovarian surgery† 12/4036 (<1%) 10/4087 (<1%) 1·21 (0·53–2·81)
Bladder or bowel damage following surgery†‡ 0/100 0/117 ..
Bowel obstruction§ 2/4036 (<1%) 1/4087 (<1%) 2·03 (0·18–22·38)
Reproductive status
Women assessed 4036 4087 ..
Involuntary infertility 85/4036 (2%) 107/4087 (3%) 0·80 (0·61–1·06)
Use of fertility treatments 10/4035 (<1%) 12/4086 (<1%) 0·84 (0·36–1·94)
Subsequent pregnancies
Women with a subsequent pregnancy (excludes 17 closure, 30 non-closure 
women pregnant at time of assessment)
1669 1675 ..
Ectopic pregnancy 5/1669 (<1%) 5/1675 (<1%) 0·99 (0·29–3·41)
Missing data are <1% unless otherwise stated. *After the CORONIS birth and before any subsequent pregnancy, any new onset or worsening. †Not related to pregnancy. 
‡Excluding diagnostic laparoscopy and diagnostic laparotomy. §After the CORONIS birth, any new onset. 
Table 4: Outcomes associated with closure of peritoneum
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characteristics of the women at trial entry and short-term 
outcomes using χ² tests, overall, and by intervention pair.
All analyses were done with Stata/SE (version 13). The 
CORONIS trial is registered with Current Controlled 
Trials, number ISRCTN31089967.
Role of the funding source
The funders of the study had no role in the design, data 
collection, analysis, interpretation, or writing of the 
report. The corresponding author had full access to all 
the data in the study and had ﬁ nal responsibility for the 
decision to submit for publication.
Results
Between Sept 1, 2011, and Sept 30, 2014, 13 153 (84%) of 
15 633 women were followed up in Argentina, Chile, Ghana, 
India, Kenya, Pakistan, and Sudan (ﬁ gure 1, appendix). Of 
the women eligible for follow-up, very few women opted out 
(90/15 633 [1%]), and 2391 (15%) could not be assessed. 
89 women were known to have died from the time of trial 
entry to the time of follow-up (ﬁ gure 1, appendix).
The mean duration between trial entry and follow-up was 
3·8 years (SD 0·86; range 2·3–6·9; ﬁ gure 1). 11 326 (86%) 
women had a formal face-to-face assessment and 1827 (14%) 
were interviewed by telephone. Of 380 women who had a 
hospital admission for a speciﬁ ed range of disorders, 
hospital notes could be checked for 328 (86%) of them. 
5815 (44%) of 13 153 women had a subsequent pregnancy 
during the period of follow-up, which was substantially 
lower than anticipated. Of the 4992 women who had a 
subsequent viable pregnancy, 3328 (66%) had a repeat 
caesarean section before labour starting.
The characteristics and selected short-term outcomes of 
women assessed in the study were well balanced between 
the randomised groups of the study (appendix). Those 
women assessed in the follow-up study were broadly 
similar to those not included. However, women included 
were slightly older, were more likely to have had their 
second caesarean section at the time of trial entry, were 
more likely to have had their CORONIS caesarean section 
during labour, and were less likely to have experienced a 
stillbirth or early death of their CORONIS baby. 
Importantly, there was no diﬀ erence in the incidence of 
the primary outcome between those included and those 
not included in the analysis (appendix).
The outcomes reported for diﬀ erent intervention pairs 
varied based on a prespeciﬁ ed assessment of biological 
plausibility. Tables 1 to 5 show the primary analysis of 
the main comparisons of interest. For blunt versus sharp 
abdominal entry, there was no evidence of a diﬀ erence 
in the risk of abdominal hernias in women and no 
evidence of a diﬀ erence in the risk of death or serious 
pinteractionBlunt Sharp Risk ratio
(95% CI)(number of events/
total number)
(number of events/
total number)
(number of events/
total number)
(number of events/
total number)
(number of events/
total number)
(number of events/
total number)
Abdominal hernias
 None
 One
 12/2776
 11/1102
 23/2781
 12/1092
 0·52 (0·26–1·05)
 0·91 (0·40–2·05)  0·31
A Abdominal entry: none and one previous caesarean section
pinteractionExteriorisation Intra-abdominal Risk ratio
(95% CI)
Subgroup
Subgroup
Involuntary infertility
 None
 One
 81/2689
 28/1403
 85/2708
 36/1428
 0·96 (0·71–1·29)
 0·80 (0·49–1·30) 0·52
Ectopic pregnancy
 None
 One
 3/1162
 1/465
 4/1174
 4/458
 0·76 (0·17–3·39)
 0·25 (0·03–2·19)  0·52
10·250·125 4 820·5
Favours intra-abdominal repairFavours exteriorisation
10·250·125 4 820·5
Favours sharp entryFavours blunt entry
B Repair of uterus: none and one previous caesarean section
pinteractionSingle Double Risk ratio
(95% CI)
Subgroup
Woman’s death
 None
 One
Stillbirth
 None
 One
Neonatal death
 None
 One
All caesarean sections
 None
 One
Other pregnancy complications (composite)
 None
 One
Uterine rupture
 None
 One
Uterine scar dehiscence
 None
 One
Placenta praevia
 None
 One
Morbidly adherent placenta
 None
 One
Abruption
 None
 One
Post-partum haemorrhage
 None
 One
Severe infection within 6 weeks post partum
 None
 One
Hysterectomy up to 6 weeks post partum
 None
 One
Manual removal of placenta
 None
 One
 16/3169
 9/1444
 25/3167
 7/1454
 0·64 (0·34–1·20)
 1·30 (0·48–3·48) 0·23
 20/1161
 14/469
 23/1193
 5/453
 0·80 (0·49–1·63)
 2·71 (0·97–7·51)  0·07
 22/1140
 10/455
 23/1168
 11/448
 0·98 (0·55–1·76)
 0·90 (0·38–2·12)  0·87
 854/1161
 458/469
 909/1193
 444/453
 0·97 (0·88–1·06)
 1·00 (0·88–1·14) 0·70
 25/1147
 13/462
 23/1179
 9/444
 1·12 (0·64–1·96)
 1·39 (0·60–3·21)  0·67
 1/1148
 0/462
 1/1179
 1/445
 3/1147
 1/462
 1/1179
 1/445
 1·03 (0·06–16·42)
    Not estimable
 0/1147
 5/462
 3/1179
 1/445
 3·08 (0·32–29·55)
 0·96 (0·06–15·31) 0·52
 0/1147
 0/462
 2/1179
 0/445
    Not estimable
 4·82 (0·56–41·22)
 4/1148
 2/462
 4/1179
 0/445
    Not estimable
    Not estimable
 4/1148
 4/462
 6/1179
 1/445
 1·03 (0·26–4·11)
    Not estimable
 11/1148
 3/462
 9/1179
 6/444
 0·68 (0·19–2·42)
 3·85 (0·43–34·34)
 1·26 (0·52–3·02)
 0·48 (0·12–1·91)  0·25
 0·18
 0/1148
 1/462
 1/1179
 0/445
    Not estimable
    Not estimable
 4/1148
 0/462
 0/1179
 0/445
    Not estimable
    Not estimable
10·250·125 4 820·5
Favours double layerFavours single layer
C Closure of uterus: none and one previous caesarean section
Figure 2: Subgroup analyses of women with no or one previous caesarean 
section for (A) abdominal entry (blunt vs sharp), (B) repair of uterus 
(exteriorisation vs intra-abdominal), and (C) closure of uterus (single vs 
double layer)
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morbidity in the children born at the time of trial entry 
(table 1). This latter ﬁ nding was unchanged in the 
secondary analysis, which included stillbirths with death 
or serious morbidity (appendix). For exteriorisation of 
the uterus versus intra-abdominal repair, we noted no 
evidence of a diﬀ erence in the risk of involuntary 
infertility or ectopic pregnancy (table 2). For single 
versus double layer closure of the uterus, there was no 
evidence of a diﬀ erence in maternal death, or a range of 
adverse pregnancy outcomes including uterine rupture 
or dehiscence. This ﬁ nding was unchanged when the 
denominator was all women assessed (appendix). The 
absolute risk of uterine rupture was very low (one per 
1000 women with a subsequent pregnancy), as was the 
risk for many other serious adverse outcomes in a 
subsequent viable pregnancy (table 3). For closure versus 
non-closure of the peritoneum, outcomes relating to 
symptoms associated with pelvic adhesions did not 
diﬀ er between groups (table 4). For chromic catgut 
versus polyglactin-910 sutures for uterine repair, we 
noted no evidence of a diﬀ erence in the main 
comparisons for adverse pregnancy outcomes in a 
subsequent pregnancy (table 5). This ﬁ nding was 
unchanged when the denominator was all women 
assessed (appendix). Similarly none of the secondary 
comparisons for all the intervention pairs diﬀ ered 
between groups (appendix).
The prespeciﬁ ed subgroup analyses showed similar 
eﬀ ects across the strata used (ﬁ gures 2–5). The one 
exception was chromic catgut versus polyglactin-910 for 
uterine repair by none versus one caesarean section on 
the composite outcome of other pregnancy outcomes 
(test for interaction p=0·03), and one of its components, 
postpartum haemorrhage (test for interaction p=0·01; 
ﬁ gure 3B). This ﬁ nding suggests there might be a 
diﬀ erential eﬀ ect, with polyglactin-910 favoured for the 
ﬁ rst caesarean section and chromic catgut favoured for 
the second caesarean section. In view of the fact that we 
recorded no eﬀ ect for this outcome overall and that the 
number of events is very small, this signiﬁ cant diﬀ erence 
might be spurious.
Sensitivity analyses on all the main comparisons noted 
similar eﬀ ect sizes and conﬁ dence intervals (not 
presented, available on request). In view of the perception 
that substantial risks are associated with caesarean 
section, especially during subsequent pregnancies, and 
the paucity of data for these risks in many of these 
countries, it was surprising to note how uncommon 
severe adverse outcomes were, although the data suggest 
some regional variation in the incidence of these 
disorders (appendix). In particular, we recorded a low 
overall incidence of problems with placentation, such as 
morbidly adherent placenta, or placenta praevia.
(number of events/
total number)
(number of events/
total number)
pinteractionClosure Non-closure Risk ratio
(95% CI)
Subgroup
Pelvic pain
 None
 One
Diagnostic laparoscopy/laparotomy
 None
 One
Hysterectomy or tubal/ovarian surgery
 None
 One
Bowel obstruction
 None
 One
Involuntary infertility
 None
 One
Ectopic pregnancy
 None
 One
 114/2567
 91/1469
 142/2589
 89/1498
 0·81 (0·64–1·03)
 1·04 (0·79–1·38) 0·18
 0/2567
 1/1469
 1/2589
 3/1498
    Not estimable
 0·34 (0·04–3·26)
 7/2567
 5/1469
 6/2589
 4/1498
 1·18 (0·40–3·50)
 1·27 (0·34–4·74) 0·93
 1/2567
 1/1469
 1/2589
 0/1498
 1·01 (0·06–16·12)
    Not estimable
 0·07
 72/2567
 13/1469
 84/2589
 23/1498
 0·86 (0·63–1·18)
 1·58 (0·29–1·13) 0·29
 4/1251
 1/418
 1/1270
 4/405
 4·05 (0·45–36·18)
 0·24 (0·03–2·17)
10·250·125 4 820·5
Favours non-closureFavours closure
A Closure of peritoneum: none and one previous caesarean section
 
(number of events/
total number)
(number of events/
total number)
pinteractionCatgut PG-910 Risk ratio
(95% CI)
Subgroup
B Uterine repair sutures: none and one previous caesarean section
Woman’s death
 None
 One
Stillbirth
 None
 One
Neonatal death
 None
 One
All caesarean sections
 None
 One
Other pregnancy complications (composite)
 None
 One
Uterine rupture
 None
 One
Uterine scar dehiscence
 None
 One
Placenta praevia
 None
 One
Morbidly adherent placenta
 None
 One
Abruption
 None
 One
Post-partum haemorrhage
 None
 One
Severe infection within 6 weeks post partum
 None
 One
Hysterectomy up to 6 weeks post partum
 None
 One
Manual removal of placenta
 None
 One
 17/2903
 5/1664
 23/2906
 5/1658
 0·74 (0·40–1·38)
 1·00 (0·29–3·46) 0·67
 34/1213
 9/473
 20/1193
 13/478
 1·67 (0·96–2·89)
 0·70 (0·30–1·64)  0·09
 17/1179
 10/464
 16/1171
 11/465
 1·05 (0·53–2·07)
 0·83 (0·36–1·92)  0·68
 1013/1212
 459/473
 975/1193
 474/478
 1·02 (0·94–1·12)
 0·98 (0·86–1·11)  0·58
 34/1196
 8/464
 20/1177
 15/469
 1·67 (0·97–2·89)
 0·54 (0·23–1·26)  0·03
 2/1196
 1/464
 1/1178
 0/469
 2/1196
 0/464
 1/1177
 2/469
 1·97 (0·18–21·70)
    Not estimable
 4/1196
 4/464
 3/1177
 5/469
 1·31 (0·29–5·85)
 0·81 (0·22–2·99)
 0·64
 2/1196
 0/464
 2/1177
 1/469
 1·97 (0·18–21·68)
    Not estimable
 6/1196
 0/464
 1/1178
 1/469
 0·98 (0·14–6·97)
    Not estimable
 7/1196
 1/464
 1/1178
 6/469
 5·91 (0·71–49·01)
    Not estimable
 12/1196
 4/464
 6/1178
 3/469
 6·89 (0·85–55·95)
 0·17 (0·02–1·39)
 1·97 (0·74–5·23)
 1·35 (0·30–5·99)  0·69
 0·01
 1/1197
 0/464
 0/1178
 2/469
    Not estimable
    Not estimable
 4/1197
 1/464
 7/1178
 0/469
 1·56 (0·17–1·92)
    Not estimable
10·250·125 4 820·5
Favours PG-910Favours catgut
Figure 3: Subgroup analyses of women with no or one previous caesarean 
section for (A) closure of peritoneum (closure vs non-closure), (B) uterine 
repair sutures (catgut vs PG-910)
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Discussion
The CORONIS trial compared ﬁ ve intervention pairs 
that were deemed the most important unanswered 
questions about the surgical techniques used at caesarean 
section in low-income and middle-income country 
settings. Despite the very large size of this trial, we did 
not ﬁ nd one technique that results in improved outcomes 
for women when compared with the others.
The main strengths of this study are its size, the 
completeness of follow-up, the rigorous data collection 
process, and the participation of several countries. 
CORONIS is the largest trial undertaken so far to 
investigate the eﬀ ect of using diﬀ erent surgical techniques 
for caesarean section, and having 84% of eligible women 
followed up by a detailed medical interview at least 3 years 
after their caesarean section, with checking of hospital 
admission notes, represents a very substantial undertaking. 
The trial was done in Africa, South America and south 
Asia, which gives the results broad generalisability across 
the diﬀ erent country settings.
However, our study has several limitations. The 
participating centres were generally large referral 
hospitals with an active interest in research. The incidence 
of adverse outcomes might be higher in other settings, 
such as in less well-resourced hospitals. However, for 
several outcomes, incidence varied between diﬀ erent 
settings (appendix); however, the absence of any 
detectable eﬀ ect was consistent across diﬀ erent settings, 
suggesting that the results will be generalisable given a 
reasonable range of incidence rates.
The incidence of a subsequent pregnancy in this group of 
women was lower than originally anticipated. Although 
there were no data to inform the likely subsequent 
pregnancy rate in the participating countries, we estimated 
that up to 80% of women would have a pregnancy in the 
3 years after trial entry. The incidence of pregnancy was 
44%, which limited the power of the study to detect 
diﬀ erences in outcomes between the inter vention pairs. 
Additionally, the incidence of caesarean section before 
labour onset in a subsequent pregnancy was very high. As 
might be expected, almost all women recruited to the trial 
at their second caesarean section went on to deliver by 
caesarean section for their subsequent births. However, 
many women who had their ﬁ rst caesarean section at the 
time of recruitment to the trial also went on to have a pre-
labour caesarean section in their subsequent pregnancy. 
This outcome probably accounted for the very low incidence 
of several adverse pregnancy outcomes such as uterine 
rupture, which is strongly associated with labour.8 Similarly, 
a long interpregnancy interval is protective against uterine 
rupture and women in this study had a longer interval 
between pregnancies than anticipated, perhaps because 
these sites gave clear advice to avoid pregnancy for at least 
1 year (and in some instances 2 years) after a caesarean 
section. The incidence of non-pregnancy related outcomes 
was also lower than anticipated. This ﬁ nding limits the 
power of the study to detect anything but large eﬀ ect sizes, 
but does provide reassurance that the risk of outcomes after 
caesarean section in these settings is generally low.
Despite the high quality of care provided in the 
participating sites, medical note taking and archiving 
were not always thorough. Notes were found for 86% of 
the 380 women when these were sought, but often they 
contained little detail at subsequent surgery, especially in 
relation to the presence or absence of pelvic adhesions, 
which was only mentioned in 41 sets of notes. Similarly, 
recording of the number of units given during blood 
transfusions was often poor. This was complicated 
further by women presenting with later morbidity or 
subsequent pregnancies at hospitals other than those 
where they had been recruited.
However, despite these limitations, this study provides 
important insights into the epidemiology of outcomes 
after caesarean section within these diﬀ erent settings. Our 
Figure 4: Subgroup analyses of women with caesarean section before or in labour for closure of uterus 
(single vs double layer)
(number 
of events/
total number)
(number 
of events/
total number)
pinteractionSingle Double Risk ratio
(95% CI)
Subgroup
Closure of uterus: before and in labour
Woman’s death
 Before labour
 In labour
Stillbirth
 Before labour
 In labour
Neonatal death
 Before labour
 In labour
Mode of delivery
 Before labour
 In labour
Other pregnancy complications (composite)
 Before labour
 In labour
Uterine rupture
 Before labour
 In labour
Uterine scar dehiscence
 Before labour
 In labour
Placenta praevia
 Before labour
 In labour
Morbidly adherent placenta
 Before labour
 In labour
Abruption
 Before labour
 In labour
Post-partum haemorrhage
 Before labour
 In labour
Severe infection within 6 weeks post partum
 Before labour
 In labour
Hysterectomy up to 6 weeks post partum
 Before labour
 In labour
Manual removal of placenta
 Before labour
 In labour
 11/2089
 14/2524
 14/2065
 18/2556
 0·78 (0·35–1·71)
 0·79 (0·39–1·58)  0·99
 12/683
 22/947
 12/686
 16/960
 1·00 (0·45–2·23)
 1·39 (0·73–2·65)  0·53
 8/670
 24/925
 10/674
 24/942
 0·80 (0·32–2·04)
 1·02 (0·58–1·79)  0·67
 489/683
 823/947
 496/686
 857/960
 0·99 (0·87–1·12)
 0·97 (0·88–1·07)  0·82
 15/673
 23/936
 14/679
 18/944
 1·08 (0·53–2·22)
 1·29 (0·70–2·37)  0·72
 1·00
 1/674
 0/936
 1/680
 1/944
 2/673
 2/936
 3/680
 1/944
 1·01 (0·06–16·10)
    Not estimable
 1/673
 4/936
 3/680
 1/944
 0·34 (0·04–3·23)
 4·03 (0·45–36·03)
 2·02 (0·18–22·23)
 2·02 (0·18–22·21)
 0·12
 0·78
 0/673
 0/936
 1/680
 1/944
 4/674
 2/936
 3/680
 1/944
    Not estimable
    Not estimable
 2/674
 6/936
 4/680
 3/944
 1·35 (0·30–5·99)
 2·02 (0·18–22·21)
 5/674
 9/936
 3/679
 12/944
 0·50 (0·09–2·74)
 2·02 (0·51–8·04)
 1·68 (0·40–7·00)
 0·76 (0·32–1·79)  0·35
 0·21
 0/674
 1/936
 0/680
 1/944
    Not estimable
    Not estimable
 1/674
 3/936
 0/680
 0/944
    Not estimable
 1·01 (0·06–16·10)
10·250·125 4 820·5
Favours double layerFavours single layer
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ﬁ ndings provide a clearer understanding of later morbidity, 
especially in relation to subsequent births, and for the ﬁ rst 
time, allows quantiﬁ cation of the risk of a range of long 
term outcomes associated with caesarean section.
We noted some beneﬁ t associated with chromic catgut 
when compared with polyglactin-910 for uterine repair in 
the immediate post-caesarean section period in our 
previous report.1 The ﬁ nding of no diﬀ erence between 
suture materials in the longer term is less surprising. The 
short-term diﬀ erence recorded was an increased risk of 
blood transfusion in the polyglactin-910 group. This 
increase would be unlikely to result in longer term eﬀ ects 
unless increased short-term bleeding at the uterine incision 
site weakened the integrity of the uterine scar for the next 
pregnancy. The ﬁ nding of a signiﬁ cant diﬀ erence in the 
incidence of postpartum haemorrhage in the subgroup 
analysis with polyglactin-910 being favoured for the ﬁ rst 
caesarean section and chromic catgut being favoured for 
the second caesarean section has little biological plausibility 
and might be a spurious ﬁ nding. However, this association 
between suture material and haemorrhage complications 
in both short term and long term outcome is intriguing.
The publication of the short-term outcomes of this trial 
showed the importance of considering the potentially 
more important longer term consequences of diﬀ erent 
caesarean section techniques before making 
recommendations for clinical practice. Despite the lack 
of power to detect modest diﬀ erences in rare, but serous 
events, there is no evidence to favour one technique over 
another with respect to a range of clinical outcomes. 
Therefore, other considerations will probably guide 
clinical practice, such as surgeon preference and 
economic and organisation factors. Furthermore, the 
implications for clinical practice are becoming clearer. 9–11 
For example, with respect to the suture material used for 
uterine scar closure, there is no evidence to support the 
use of the substantially more expensive polyglactin-910. 
Additionally, current recommendations that state that 
blunt abdominal entry should be preferred over sharp 
entry are not supported by this, the largest trial ever 
undertaken addressing this comparison. 12,13 Although 
some studies have shown that blunt abdominal entry can 
also result in a shorter operating time, this does not seem 
to lead to measurable improvements in clinical outcomes. 
However, shorter operating times might lead to more 
eﬀ ective use of theatre time in centres with large 
numbers of caesarean sections being done. Additionally, 
guidance stating that peritoneal closure is not 
recommended cannot be supported on the grounds of 
the clinical superiority of non-closure.14–16 The use of less 
suture material could decrease costs, which might be a 
major consideration in resource-poor countries. Non-
closure also results in a shorter operating time that could 
oﬀ er organisational advantages.
We were unable to detect any diﬀ erences in the risk of 
uterine rupture or dehiscence when comparing single 
versus double layer uterine closure, which means that this 
debate will continue. It seems unlikely that any further 
trial of suﬃ  cient size will be undertaken to address this 
question, making us reliant on observational studies to 
explore this hypothesis.17–22 In view of the level of detail 
available in routine notes in the settings in which this trial 
was undertaken, as well as in those of a similar trial in the 
UK,23 this will be a diﬃ  cult question to answer. What we 
can be sure of is that like other serious consequences of 
caesarean section, uterine rupture is very rare, so the 
population eﬀ ect of the diﬀ erent techniques used at 
caesarean section on subsequent adverse outcomes such 
as perinatal mortality will be very small.
During the original trial we collected details about all 
the surgical techniques used for the caesarean section. 
We now have the opportunity to explore what other 
aspects of the operation, other than those tested within 
(number 
of events/
total number)
(number 
of events/
total number)
pinteractionCatgut PG-910 Risk ratio
(95% CI)
Subgroup
Uterine repair sutures: before and in labour
Woman’s death
 Before labour
 In labour
Stillbirth
 Before labour
 In labour
Neonatal death
 Before labour
 In labour
All caesarean sections
 Before labour
 In labour
Other pregnancy complications (composite)
 Before labour
 In labour
Uterine rupture
 Before labour
 In labour
Uterine scar dehiscence
 Before labour
 In labour
Placenta praevia
 Before labour
 In labour
Morbidly adherent placenta
 Before labour
 In labour
Abruption
 Before labour
 In labour
Post-partum haemorrhage
 Before labour
 In labour
Severe infection within 6 weeks post partum
 Before labour
 In labour
Hysterectomy up to 6 weeks post partum
 Before labour
 In labour
Manual removal of placenta
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Figure 5: Subgroup analyses of women with caesarean section before or in labour for uterine repair sutures 
(catgut vs PG-910)
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CORONIS, might be worth exploring in subsequent 
trials in terms of their eﬀ ect on both short-term and 
long-term outcomes for women. 
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